A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. (Q44088535)

29 November 2017

title

A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. (English)

1 reference

29 November 2017

Hye Joo Shin

1

1 reference

29 November 2017

Hyoung Ja Kim

2

1 reference

29 November 2017

Jong Hwan Kwak

3

1 reference

29 November 2017

Hyung Ok Chun

4

1 reference

29 November 2017

Je Hak Kim

5

1 reference

29 November 2017

Hokoon Park

6

1 reference

29 November 2017

Dong Hyun Kim

7

1 reference

29 November 2017

Yong Sup Lee

8

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

29 November 2017

published in

1 reference

29 November 2017

volume

12

1 reference

29 November 2017

issue

17

1 reference

29 November 2017

page(s)

2313-2316

1 reference

Purification of cGMP-binding protein phosphodiesterase from rat lung

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Cyclic GMP phosphodiesterase inhibitors. 1. The discovery of a novel potent inhibitor, 4-((3,4-(methylenedioxy)benzyl)amino)-6,7,8-trimethoxyquinazoline

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Synthesis and cyclic GMP phosphodiesterase inhibitory activity of a series of 6-phenylpyrazolo[3,4-d]pyrimidones

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Novel, potent, and selective phosphodiesterase 5 inhibitors: synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

A new prenylated flavonol from the roots of Sophora flavescens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. III.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

Phosphodiesterase inhibitors. Do the risks outweight the benefits?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900401-8

7 January 2021

10.1016/S0960-894X(02)00401-8

Identifiers

DOI

1 reference

29 November 2017

1 reference